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Introduction
In 2015, stroke-related disease caused more than 6 million deaths worldwide and is considered as one of the most common causes of death and disability among adults [1, 2] For the past 2 decades a significant decline in overall mortality and incidence of stroke have been observed in many West European countries [3] [4] [5] [6] . In Sweden, the incidence of ischemic stroke (IS) has decreased among older people, but increased among younger adults (<45 years) [7] . The underlying causes for this trend are not well understood, but are of major concern if those who are young carry this increase with them as they age, which will put additional strain on the healthcare system. Therefore, information regarding occurrence of stroke is important for planning of future strategies in prevention and care.
The absolute number of cases of stroke is expected to increase in the near future because of the growing older population. According to a recent report from Canada, the projected number of people experiencing effects of stroke will increase by between 62% and 79% from 2013 to 2038 [8] . Similar projections have been reported in other regions, including Western Australia and United States, with an overall increase in prevalence over time [9, 10] . In Sweden, the majority of all stroke cases (~85%) are ischemic stroke (IS), but trends and current prevalence of IS have not been well quantified in the Swedish population. The present study aimed to investigate age-and sex-specific time trends of the prevalence and absolute number of IS survivors in Sweden from 1995-2010.
Materials and methods

Study population
In Sweden, a universal health care system is provided at a low cost to all citizens. Hospitals are required to report the principal and contributory diagnosis to the Inpatient Register (IPR) and the Cause of Death Register. The IPR was established in 1964 and has been operating on a national basis since 1987 with a complete national coverage of all hospital discharge diagnoses, while the Cause of Death Register has been in operation since 1961. For the purpose of this study, data were obtained by linkage with the IPR and Cause of Death Register through the Swedish 10-digit personal identifier.
In the present study, all men and women older than 18 years who were hospitalized at least once during 1995-2010 and survived with a principal discharge diagnosis of IS were included. Patients were stratified according to age group (18-44, 45-54, 55-64, 65-74, 75-84, and !85 years) and admission years. All discharge diagnoses were coded according to the International Classification of Disease (ICD) system. The ICD-8 was used from 1968 to 1987, ICD-9 from 1987 to 1996, and ICD-10 from 1996 onwards. Ischemic stroke was coded as ICD-8 and ICD-9 code 434 and 436 and ICD-10 codes I63 and I64.
Administrative data from the Swedish IPR and Cause of Death register was used to estimate the prevalence of IS over time for a specific age and year. The prevalence of IS includes 2 subsets of prevalent cases: 1) incident cases that survive up to an index date and 2) cases that were incident before the start of the registry and survived up to the index date. The second data set was created using the mean incidence rate from the IPR to estimate the annual number of incident cases for each age and sex. All survival estimates before 1987 were adjusted to follow the mortality rate in the general population. The counting method used to accumulate prevalent cases of IS for the datasets was described more formally by Gail et al [11] . The Swedish general population from Human Mortality Database was used as the reference group when calculating the prevalence of IS in the population [12] . Prevalence is reported as patients per 10,000 population.
Statistical analysis
Prevalence and survival were estimated by SAS software version 9. [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] was used as independent variable, the analysis was stratified by age group. A linear model with minimum four data point between each jointpoint and a maximum of 2 joinpoints were allowed in which the software finds the optimal number of joinpoints. The slopes (S) and intercepts were estimated using least squares and the number and position of the joinpoints were automatically selected using grid search. Within each interval, the APC were calculated as: (exp (Si)-1) Ã 100, and the average APC (AAPC) were calculated from the weighted average (with number of data points within each interval as weight) of slopes. The upper and lower 95% confidence interval (CI) for the APC within each interval was calculated from the estimated variances of the slopes (Vi): (exp(Si+/-t Ã Vi-1) Ã 100, and the 95% CI of the AAPC was calculated from the pooled variance and average slope.
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Results
From 1995-2010, the number of patients with IS aged 18 to !85 years in Sweden increased from 129,418 to 148,778. The number of male patients increased from 70,958 to 79,817 and that of female patients increased from 58,460 to 68,961, corresponding to a relative increase of 12.5% and 18.0%, respectively (S1 Table) . The largest relative increase was observed in age groups 55-64 years and !85 years, by 49% and 28%, respectively, in men and 61% and 47%, respectively, in women (S1B Fig for men and S1C Fig for women) . During the same period there was an approximate increase of~40% in the total population size among those aged 55-64 years and !85 years (S2 Fig) .
Overall prevalence Table 1 shows the prevalence of IS in the total population and Table 2 the joinpoint analysis of trends in prevalence in Sweden by age, sex and year. The overall prevalence of surviving patients who had ever been hospitalized with IS aged 18 to !85 years was 189 patients per 10,000 population in 1995, which increased to 202 patients per 10,000 population in 2000 with an APC of 1.6% (95% CI 1.4 to 1.7). The prevalence remained stable until 2006, followed by a decrease (APC: -0.8%, 95% CI -1.0 to -0.6) and with a final prevalence of 199 patients per 10,000 population in 2010.
In the youngest age group of 18-44 years, the prevalence increased with an APC of 2.1% (95% CI 0.9 to 3.4) from 6.4 in 1995 to 6.9 patients per 10,000 population in 1998. The prevalence continued to increase but at a slower pace with an APC of 0.7% (95% CI 0.6 to 0.9) throughout the study and with a final prevalence of 7.6 patients per 10,000 population in 2010. An increase in overall prevalence was observed among those aged 45-54 years with an APC of 3.3% (95% CI 2. was then followed by a decrease (APC: -1.1%, 95% CI -1.5 to -0.7) to 920 patients per 10,000 population in 2010. In the oldest age group !85 years, the overall prevalence was estimated as 1471 patients per 10,000 population in 1995 which remained stable until 2002. Afterwards there was a slight decline in prevalence (APC: -0.3%, 95% CI -0.5 to -0.1) throughout the study to 1453 patients per 10,000 population in 2010.
Trends in age-and sex-specific prevalence
The overall prevalence of IS in men aged 18 to !85 years increased with an APC of 0.9% (95% CI 0.7 to 1.1) from 212 in 1995 to 220 patients per 10,000 population 2000 and then remained stable until 2005, followed by a decrease (APC: -0.4%, 95% CI -0.6 to -0.3) to 217 patients per 10,000 population in 2010 (Tables 1 and 2 ). Among women the overall prevalence increased with an APC of 2.3% (95% CI 2.2 to 2.5) from 167 in 1995 to185 patients per 10,000 population in 2000. The prevalence rates continued to increase (APC: 0.3%, 95% CI 0.1 to 0.5) but at a slower pace until 2006 and with a prevalence of 190 patients per 10,000 population, then declining with an APC of -1.1% (95% CI -1.3 to -0.8) to 183 patients per 10,000 population in 2010. Trends in the overall prevalence of IS differed markedly by age and sex. In men, the prevalence in those aged 18-44 years increased slightly but continuously with an APC of 1.0% (95% CI 0.8 to 1.2) throughout the study from 6.0 in 1995 to 7.1 patients per 10,000 population in 2010, a relative increase of 18.3% (Table 1 and Fig 1B) . The prevalence among those aged 45-54 years increased during the first years with an APC of 2.8%, (95% CI 2.0 to 3.7) until 1999, followed by a slight decrease (APC -0.7, 95% CI -0.9 to -0.5) throughout the study and with a final prevalence of 50.7 patients per 10,000 population in 2010. For women, a similar pattern was observed among those aged 18-44 years. Prevalence increased with an APC of 3.3% (95% CI 0.4 to 6.3) from 6.9 in 1995 to 7.4 patients per 10,000 population in 1997. The rates continued to increase from 1997-2005 but at a slower pace (APC: 1.0%, 95% CI 0.6 to 1.3) after which the rates remained stable throughout the study with a final prevalence of 8.1 patients per 10,000 population in 2010, and with a relative increase of 17.4% (Fig 1C) . During 1995-2000 the prevalence among women aged 45-54 years increased with an APC of 3.1% (95% CI 2.3 to 3.9) from 32 to 37 patients per 10,000 population, followed by a slight decrease until 2007 (APC: -0.7%, 95% CI -1.3 to -0.2) and then remained stable throughout the study with a final prevalence of 37 patients per 10,000 population in 2010. The prevalence of IS among men aged 55-64 years increased throughout the study with an APC of 0.3% (95% CI 0. 
Discussion
Our study shows that the overall number of patients who were hospitalized with IS increased by 12.5% in men and 18.0% in women from 1995-2010. An overall increase in prevalence of IS was observed during most of the mid to late 1990s, but leveled off after 2000 and remained stable until 2006, followed by a slight decline (APC: -0.8%, 95% CI -1.0 to -0.6) and with a final prevalence of 199 patients per 10,000 population in 2010 (Tables 1 and 2 ). Age-specific trends in prevalence markedly differed. In the youngest age group of 18-44 years, the prevalence of IS increased throughout the study period. However, in those aged 45-54 years the prevalence increased from 1995-1999, followed by a slight decline (APC: -0.7%, 95% CI -1.1 to -0.4) until 2006 and then remained stable at 43.8 patients per 10,000 population in 2010. In the oldest age group of !85 years the overall prevalence of IS remained stable during the first years of the study, after 2002 there was a slight decline (APC: -0.3%, 95% CI -0.5 to -0.1) until 2010 with a final estimate of 1453 patients per 10,000 population.
Most studies on stroke prevalence have only considered overall stroke while we estimated IS only. In an Italian study, the overall prevalence of stroke in persons aged !15 years was estimated as 1.47% in 2004, but this was based on comparatively few cases [13] . In England, Scotland, and Wales, the prevalence was 1.7% in 2006/2007, while in Australia, the estimate prevalence in 2009 was 1.9% in men and 1.3% in women [14, 15] . Canada reported a prevalence of stroke of 1.14% in 2009/2010, and in United States, stroke prevalence remained stable at 2.6% from 2006-2010 [8, 16] . Previous studies were either based on specific regions, selfreported, a national survey, or conducted only for a short period of time [13, 15, 16] . We aimed to investigate trends in the prevalence of IS for a whole nation over time based on national hospital records, based on the net effect of the incidence of IS and mortality for each year. This provides the absolute number of patients with IS and enabled us to estimate trends in prevalence of IS. We found that the overall prevalence of IS in Sweden increased during the mid to late 1990s until the beginning of the 2000s, and then remained stable until 2006 after which it declined slightly until 2010 (199 per 10,000 population), but with varying trends between age groups (Table 1) . Decline in overall prevalence of IS might to some extent be explained by improvements in treatments and changes in cardiovascular risk factors over time e.g. lower blood pressure levels and smoking rates [17] [18] [19] [20] . This might be explained by dietary changes and better antihypertensive treatment in the general population over time but also due to intervention campaigns and implemented smoking bans in public spaces. Additionally, decreases in cholesterol levels have been observed in Sweden for the past years which explained most of the decline in coronary heart disease mortality in Sweden [20] . Notably, the overall prevalence rate in the youngest age groups steadily increased throughout the study (Table 2) . A possible explanation for the increase in prevalence could be due to better diagnostic methods over time such as the use of magnetic resonance imaging. However, this would not have affected only young people in whom we observed the most marked rise in prevalence of IS. Computed tomography scan (CT) has been widely used during the study period to distinguish between ischemic and hemorrhagic stroke. According to a recent study from the Swedish Stroke Register (Riks-Stroke) a majority of stroke patients are examined with CT (>98%) [21] . The overall prevalence of IS was slightly higher in men than in women in all age groups. Similar findings were reported in Western Australia and Canada, but not in the USA, which reported a slightly higher proportion of women in people aged <60 years [8, 15, 16] . Our results of an increasing prevalence of IS in the younger age groups are in accordance with previous findings of an increasing incidence trend of IS in younger adults [22] [23] [24] . The reasons for this are not known, but could potentially be due to increasing sedentary lifestyle and obesity but also to demographic changes in population [25, 26] . Generally, the greatest increase in prevalence of IS in men and women occurred during the mid to late 1990s, followed by a stabilized or declining rate until the end of the study period. Although the prevalence of IS in some age groups remained stable or declined for a few years, the absolute number of patients increased over time, likely due to demographic changes with more people surviving into old age but also because of improved primary and secondary treatments in stroke (S2 Fig). We have demonstrated improved survival after ischemic stroke in IS patients aged 55 and younger, which likely is applicable to older patients as well [3] . The largest proportional increase was observed among those aged 55-64 years and !85 years because of the growing numbers of people in the two age groups in the general population. Additionally, recent advances and developments in the healthcare system have led to an overall improvement in survival with improvements in medical treatment and secondary prevention (e.g., increased use of anticoagulation treatment among older people after a stroke) [27] [28] [29] [30] . Because stroke is strongly correlated with age, quantifying the numbers of stroke is an important task for future healthcare planning.
Strengths and limitations
There are limitations and strengths to our study. To investigate trends in prevalence over time, large populations are often needed to identify a sufficient amount of people with IS. Therefore, the main strength of our study is the use of data from an entire nation. Because of our unique personal identification numbers, all people could be followed throughout the whole study period with virtually no loss to follow-up. This enabled study of age-specific trends in prevalence over a long time in men and women separately. Limitations include the lack of externally validated stroke diagnoses over time. However, previous studies on the use of principal diagnosis from the Swedish IPR have shown a high validity of many cardiovascular diagnoses, including stroke, especially after 2000 [31, 32] . A limitation in the present study is the lack of information on diagnostic methods because improved medical imaging modalities over time could increase detection rates of IS. However, CT scan has been widely used during the study period and is still the most common method in the evaluation of stroke and accordingly changes in detection rates are unlikely to explain the trends that we observed, or the variation between age groups [21] .
Conclusions
In conclusion, the overall prevalence of hospitalized patients with IS has increased for the past years in Sweden but at different rates over time. In most age groups, the prevalence of IS increased during the mid to late 1990s and then declined or remained stable, except in the youngest age groups where the prevalence increased throughout the study. Additionally, the absolute number of patients with IS has increased in most age groups from 1995-2010, especially in those aged 55-64 years and !85 years, which could mainly be explained by demographic factors. If this trend continues into the future, it will cause additional strain to the healthcare system. 
Supporting information
Author Contributions
Conceptualization: KWG AR.
Data curation: KWG GL.
Formal analysis: KWG GL MA.
Funding acquisition: AR.
Investigation: AR.
Methodology: KWG ZM SN GL MA LB AR.
Project administration: KWG AR.
Resources: AR.
Software: GL.
Supervision: KWG AR.
Validation: KWG ZM SN GL MA LB CJ AR.
